Key takeaways Medicare Part D generally covers Ozempic when its prescribed for an FDA-approved indication, such as treating type 2 diabetes, lowering cardiovascular risk in people with type 2 diabetes and heart disease, or reducing the risk of kidney decline in people with type 2 diabetes and kidney disease
Reddy's Laboratories', 'Samsung Bioepis', 'Viatris (Mylan)', 'Lupin Limited', 'Cipla Ltd.', 'Aurobindo Pharma', 'Torrent Pharmaceuticals', 'Zealand Pharma', 'Structure Therapeutics' Rising prevalence of diabetes and obesity across global populations drives increasing demand for effective GLP1 receptor agonists such as liraglutide and semaglutide
Meanwhile, general awareness of GLP-1 drugs has soared, KFF reports, with 82% of U.S
Rare but severe side effects could involve responses or pancreas problems
Makino Y, Miyahara T, Nitta J, Miyahara K, Seo A, Kimura M, et al